Plozasiran reduced triglycerides and APOC3 up to a mean maximum of 86% and 90% respectively in patients with severe hypertriglyceridemia $Arrowhead Pharmaceuticals (ARWR.US)$
The company's poor performance and the CEO's high pay, despite falling earnings and shareholder value, may upset shareholders. The upcoming AGM on March 14th is a chance for shareholders to hold the board and management accountable.
Arrowhead Pharmaceuticals Stock Forum
Can Arrowhead's New Obesity Drug Outperform GLP-1s? Preclinical Data Shows Key Advantage
$Arrowhead Pharmaceuticals (ARWR.US)$
Insiderd selling shares and financials dont look good. Im guessing they dont have anything in the pipeline?
$Arrowhead Pharmaceuticals (ARWR.US)$ - Alpha Early Alert 🚨 H&S 📈🎯🚀🥇 (45.00) is on the Table 🫵🏻💪🏻🥇 Find the Apex and win!
No comment yet